Medicosnext
Event: Optimizing Triage of HPV Positive Patients with p16/Ki67 Dual Stain Biomarkers: Singapore Experience
Date: Thursday, 16th May 2024
Time: 13:00 – 14:00 (GMT +8)
Location: Online
Cervical cancer screening is pivotal in detecting precancerous lesions, preventing their progression to cervical cancer. However, traditional methods like Pap cytology have limitations such as subjectivity and missed diagnoses.
Discover the groundbreaking potential of p16-Ki67 dual-biomarker immunocytochemistry in revolutionizing cervical cancer screening. Join this Roche event, with esteemed speakers, Prof. Tay Sun Kuie, Senior Consultant Obstetrician and Gynecologist at Singapore General Hospital, and Dr. Sangeeta Mantoo, Senior Consultant in Anatomical Pathology at the same institution, as they unveil the efficacy of FDA-approved CINtec® PLUS Cytology in objectively identifying transforming HPV infections, aiding in triage decisions for patients with abnormal Pap cytology or HPV-positive results.
Moderated by Dr. Richie Lazaro, Regional Pathologist APAC at Roche Diagnostics Asia Pacific Pte Ltd, this webinar promises invaluable insights into optimizing triage processes, empowering clinicians with greater certainty in patient management decisions. Don’t miss the chance to learn from the Singapore experience and explore the potential of biomarker testing in improving cervical health outcomes. Scan the QR Code below to register for the event. Register now to secure your spot!
